WHERE REGULATORY LEADERSHIP MEETS SCIENTIFIC INSIGHT
RCSS is an independent regulatory consultancy led by Dr. Nathalie Machluf, a former VP of Regulatory Affairs with extensive experience in global drug development across biological and pharmaceutical products.
RCSS provides executive-level regulatory leadership across CMC, clinical, and submission strategy, supporting biotech and pharmaceutical companies throughout the full product lifecycle — from early clinical development through global registration and post-approval.
By combining deep scientific expertise with strategic regulatory leadership, RCSS helps companies navigate complex regulatory pathways with clarity, mitigate development risks, and advance innovative products efficiently and successfully.
ONE GOAL
YOUR SUCCESS
Behind every milestone lies a greater purpose: bringing innovative treatments to patients with unmet medical needs and offering hope where treatment options remain limited.
As a passionate scientist, I’m deeply driven by the potential of innovation to transform patients’ lives. I thrive on tackling complex challenges, connecting scientific insight with critical thinking to find practical, effective solutions. I bring this mindset to every project, balancing scientific ambition with real-world time, budget, and resource constraints.
The RCSS ADVANTAGE
Regulatory Leadership. Scientific Insight.
At RCSS, clients work directly with Dr. Machluf, a former VP of Global Regulatory Affairs, combining senior regulatory leadership with scientific insight and practical experience
Global Regulatory Experience
Over 16 years in Regulatory Affairs, working with major health authorities, including the FDA, EMA, MHRA, Health Canada, and Israel’s Ministry of Health, as well as other international markets.
CMC Expertise & Successful Approvals
Leadership of global CMC regulatory strategy for a biological product, from clinical development through successful marketing authorization in the US, EU, UK, and Canada.
Clinical Development Expertise
Clinical trial design and conduct in accordance with Good Clinical Practice (GCP), supporting the generation of robust evidence of efficacy and safety.
Scientific Solutions Beyond Regulatory Affairs
A PhD in Immunology from the Weizmann Institute of Science, with expertise in scientific problem-solving, and investigations of complex scientific challenges.
Strategic Leadership & Practical Insight
Senior global regulatory leadership, combining strategic perspective and sound judgment to balance scientific objectives, regulatory expectations, and business realities.